Myomo (MYO) Asset Utilization Ratio (2017 - 2025)
Myomo (MYO) posted Asset Utilization Ratio of 1.14 for Q3 2025, up 11.7% on a QoQ basis from 1.02 in Q2 2025, and down 26.28% year-over-year from 1.55 in Q3 2024.
Myomo (MYO) Asset Utilization Ratio (2017 - 2025) Analysis & Trends
Myomo's Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 1.14 for Q3 2025.
- Quarterly Asset Utilization Ratio fell 26.28% year-over-year to 1.14 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 1.14 (down 26.28% YoY) and the FY2024 annual result came in at 1.15, down 26.34% from the prior year.
- Asset Utilization Ratio was 1.14 for Q3 2025 at Myomo, up from 1.02 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.55 in Q3 2024 and bottomed at 0.5 in Q1 2021.
- A 5-year average of 1.07 and a median of 1.14 in 2025 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2021 — Asset Utilization Ratio soared 107.82% — and 2025, when it dropped 26.28%.
- Myomo's Asset Utilization Ratio stood at 0.74 in 2021, then surged by 88.89% to 1.39 in 2022, then fell by 12.73% to 1.22 in 2023, then declined by 8.6% to 1.11 in 2024, then increased by 2.97% to 1.14 in 2025.
- Business Quant data shows MYO's Asset Utilization Ratio at 1.14 in Q3 2025, 1.02 in Q2 2025, and 0.93 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.47 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.74 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.65 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.57 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.14 |
| Jun 30, 2025 | 1.02 |
| Mar 31, 2025 | 0.93 |
| Dec 31, 2024 | 1.11 |
| Sep 30, 2024 | 1.55 |
| Jun 30, 2024 | 1.29 |
| Mar 31, 2024 | 1.26 |
| Dec 31, 2023 | 1.22 |
| Sep 30, 2023 | 1.22 |
| Jun 30, 2023 | 1.29 |
| Mar 31, 2023 | 1.27 |
| Dec 31, 2022 | 1.39 |
| Sep 30, 2022 | 1.16 |
| Jun 30, 2022 | 0.98 |
| Mar 31, 2022 | 0.81 |
| Dec 31, 2021 | 0.74 |
| Sep 30, 2021 | 0.77 |
| Jun 30, 2021 | 0.58 |
| Mar 31, 2021 | 0.50 |
| Dec 31, 2020 | 0.50 |